SCHEMBL9059545

SCHEMBL9059545

CSc1ccc(-c2ccccc2)c(NC(=N)N2CCN(C)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 3/20 0.41
CHRM3 P20309 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
POLB P06746 1/20 0.37
CYP2C9 P11712 1/20 0.36
CHEK1 O14757 1/20 0.35
KMT2A Q03164 2/20 0.35
HTR7 P34969 2/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060028 0.90 MAPT (0.45) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL9059960 0.86 MEN1 (0.38) MAPTALDH1A1CHRM3SMN1; SMN2PTGS1
SCHEMBL9536765 0.84 CHRM3 (0.44) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL9059940 0.82 CHRM3 (0.48) ALDH1A1KDM4ECHRM3SMN1; SMN2NPC1
SCHEMBL9059781 0.82 CHRM3 (0.53) MAPTALDH1A1HSD17B10KDM4ECHRM3
SCHEMBL9536114 0.80 CHRM3 (0.47) MAPTALDH1A1KDM4ECHRM3KMT2A
SCHEMBL9059684 0.77 ALDH1A1 (0.44) MAPTALDH1A1HSD17B10KDM4ESMN1; SMN2
SCHEMBL9059638 0.76 MEN1 (0.38) MAPTALDH1A1CHRM3PTGS1PTGS2
SCHEMBL9059166 0.76 CHRM3 (0.52) ALDH1A1HSD17B10KDM4ECHRM3SMN1; SMN2
SCHEMBL9059333 0.75 CHRM3 (0.52) KDM4ECHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed